🔗 Permalink

Inventor profile of:

Weizao Chen

City:

Frederick, Maryland

Country:

United States

Published Applications:

Last publication date:

2023-11-09

Top Assignees for applications by Weizao Chen

The entities that hold a legal rights for patent applications filed by inventor Chen Weizao:

The United States of America, as represented by the Secretary, Department of Health and Human Services 5 Washington, DC United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 4 Bethesda, MD United States
Zhejiang Shimai Pharmaceutical Co., Ltd. 3 Hangzhou, China
The USA, as represented by the Secretary, Department of Health and Human Services 2 Bethesda, MD United States
The United States of America, as represented by the Secretary, Dept. of Health & Human Services 1 Bethesda, MD United States
Zhejiang Shimai Pharmaceutical Co. Ltd. 1 Binjiang, China
Zhejiang Shimai Pharmaceutical Co.,Ltd. 1 Binjiang, Hangzhou, China
The United States of America as represented by the Secretary of the Department of Health and Human Services 1 Washington, DC United States
THE UNITED STATES OF AMERICA, AS REPRESENTED BY TH 1 ROCKVILLE, MD United States
FUDAN UNIVERSITY 1 Shanghai, China
The United States of America, as represented by the Secretary, Department of Health and Human Serv 1 Bethesda, MD United States
The United States of America, as Represented by the Secretary, Dept. of Health and Human Resources 1 Bethesda, MD United States

Recent patent applications by Chen Weizao

Weizao Chen from Frederick, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-11-09

US20230357410A1

Chemistry; metallurgy

PROTEASE CLEAVABLE BISPECIFIC ANTIBODIES AND USES THEREOF

#2 | 2022-04-28

US20220127367A1

Chemistry; metallurgy

Human monoclonal antibodies specific for FLT3 and uses thereof

#3 | 2021-12-16

US20210388118A1

Chemistry; metallurgy

PROTEASE CLEAVABLE BISPECIFIC ANTIBODIES AND USES THEREOF

#4 | 2021-04-22

US20210115135A1

Chemistry; metallurgy

Human monoclonal antibodies against LAG3 and uses thereof

#5 | 2019-12-05

US20190367611A1

Chemistry; metallurgy

MONOMERIC HUMAN IGG1 FC AND BISPECIFIC ANTIBODIES

#6 | 2019-11-21

US20190352408A1

Chemistry; metallurgy

Human monoclonal antibodies specific for FLT3 and uses thereof

#7 | 2018-05-03

US20180118815A1

Chemistry; metallurgy

Bispecific multivalent fusion proteins

#8 | 2018-03-29

US20180086812A1

Chemistry; metallurgy

Stabilized single human CD4 domains and fusion proteins

#9 | 2016-07-21

US20160207985A1

Chemistry; metallurgy

Anti-HIV domain antibodies and method of making and using same

#10 | 2016-02-11

US20160039904A1

Chemistry; metallurgy

STABILIZED SINGLE HUMAN CD4 DOMAINS AND FUSION PROTEINS

#11 | 2015-09-03

US20150246967A1

Chemistry; metallurgy

Human domain antibodies against components of the human insulin-like growth factor (IGF) system

#12 | 2014-09-18

US20140271646A1

Chemistry; metallurgy

Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)

#13 | 2013-05-02

US20130108636A1

Chemistry; metallurgy

High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins

#14 | 2012-08-02

US20120195897A1

Chemistry; metallurgy

Human domain antibodies against components of the human insulin-like growth factor (IGF) system

#15 | 2011-05-05

US20110104163A1

Chemistry; metallurgy

Anti-HIV domain antibodies and method of making and using same

InventorID:

221963 ⎘